[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
Colin Langan Maintained (ADNT) at Buy with Decreased Target to $50 on, Apr 1st, 2022
- 🞛 This publication is a summary or evaluation of another publication
Colin Langan of Wells Fargo, Maintained "Adient plc" (ADNT) at Buy with Decreased Target from $60 to $50 on, Apr 1st, 2022.
Colin has made no other calls on ADNT in the last 4 months.
There is 1 other peer that has a rating on ADNT. Out of the 1 peers that are also analyzing ADNT, all agrees with Colin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brian Johnson of "Barclays" Downgraded from Buy to Hold and Decreased Target to $43 on, Thursday, December 16th, 2021